Bayesian Capital Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bayesian Capital Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,900	Closed	-$203K	–	1196
2022 Q1	$203K	Buy	+10,900	New	+$196K	0.03%	651

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bayesian Capital Management's OCDX Position: Q2 2022 in Review

Bayesian Capital Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 10,900 shares — an estimated $203K sold.

Bayesian Capital Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $203K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Bayesian Capital Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Bayesian Capital Management sold 10,900 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $203K.
Bayesian Capital Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
Bayesian Capital Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $203K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.